v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 130,587 $ 147,724
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 74,300 67,016
Amortization of debt issuance costs 2,359 3,193
Loss on sale of business 3,916 0
Share-based compensation 11,367 11,944
Amortization of intangible assets 41,761 77,600
Deferred income taxes 17,267 6,056
Loss on equity investments, net 0 14,306
Other non-cash loss/(gain), net 15,819 (9,862)
Changes in operating assets and liabilities, net of the effects of divestitures:    
Accounts receivable, net (96,060) (69,440)
Inventories (24,363) 3,158
Prepaid expenses and other current assets (4,760) (6,699)
Accounts payable and accrued expenses 82,457 11,798
Income taxes payable 4,278 (9,099)
Other 1,175 2,248
Net cash provided by operating activities 260,103 249,943
Cash flows from investing activities:    
Additions to property, plant and equipment and capitalized software (57,960) (87,188)
Proceeds from the sale of business, net of cash sold 25,635 0
Other (1,281) 1,994
Net cash used in investing activities (33,606) (85,194)
Cash flows from financing activities:    
Proceeds from exercise of stock options and issuance of ordinary shares 0 4,605
Payment of employee restricted stock tax withholdings (3,512) (6,980)
Proceeds from borrowings on debt 0 500,000
Payments on debt (1,208) (566)
Dividends paid (35,456) (36,148)
Payments to repurchase ordinary shares (120,600) (10,052)
Purchase of noncontrolling interest in joint venture 0 (79,393)
Payments of debt financing costs 0 (6,376)
Net cash (used in)/provided by financing activities (160,776) 365,090
Effect of exchange rate changes on cash and cash equivalents 2,386 (4,891)
Net change in cash and cash equivalents 68,107 524,948
Cash and cash equivalents, beginning of year 593,670 508,104
Cash and cash equivalents, end of period $ 661,777 $ 1,033,052